BB
Bridgebio Pharma
BBIO13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying BBIO
Top funds mostly trimmed Bridgebio Pharma in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress1
- Top funds0 of 2 bought more, 2 sold some. Largest: Viking Global Investors, $741.0M (2% of its portfolio).
- InsidersNo buys, 38 sales in 12 months.
- Congress1 member bought (5 trades), 1 sale in 12 months.
2 funds$741.3M held1.1% avg. weightQ2: 0 bought / 2 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Congressional trading
Last 2 years · 6 disclosed trades
Members1